Evaluation of toxicity and efficacy of (186)Re-hydroxyethylidene diphosphonate in patients with painful bone metastases of prostate or breast cancer

From: The Journal of Nuclear Medicine | Date: October 1, 2000| Author: | Copyright information

Twenty-eight patients (12 men with prostate cancer, 16 women with breast cancer) were included in a phase II trial to evaluate the efficacy of 'ssRe-hydroxyethylidene diphosphonate (HEDP) on pain from bone metastasis and the toxicity of this agent.

Methods: After intravenous administration of 1295 MBq '86ReHEDP, the efficacy was evaluated by means of a daily log.

Results: We observed an objective response in 67% of prostate cancer patients and in 36% of breast cancer patients. The mean duration of response was 45 d for prostate cancer patients and 24 d for breast cancer patients. No major ...

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

Retrospective evaluation of operated stage I breast cancer patients
; ...had metachronous breast carcinoma. Two patients died with distant...About half of the patients with newly diagnosed breast carcinoma do not have axillary...study, 131 stage I breast carcinoma patients were evaluated retrospectively...
Gastrin-Releasing Peptide Receptor Imaging in Human Breast Carcinoma Versus Immunohistochemistry
; ...diagnosis suggestive of breast carcinoma and 5 patients with tamoxifen-resistant...in tumor lesions of patients with breast carcinoma and GRP-R expression...highly suggestive of breast carcinoma. These patients underwent ^sup 99m...
Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma
; ...tumor foci in patients with suspected...lesions of breast carcinoma. Methods: Whole-bo...performed on 57 patients with a previous history of breast carcinoma who were referred...metastatic breast carcinoma in patients suspected of...
A study of the patient factors affecting reconstruction after mastectomy for breast carcinoma
; ...conclude that many patients were suitable...mastectomy for breast carcinoma. It may be safely...proportion of patients who undergo it...proportion of patients with breast carcinoma who were suitable...for doing so. Patients and Methods Over...newly diagnosed ...
Metastatic breast carcinoma mimicking macronodular cirrhosis
; ...in 4 of 32 patients with breast carcinoma metastatic...ascites. The 4 patients with cirrhosis...liver in patients with metastatic breast carcinoma treated by...metastatic breast carcinoma: CT findings...liver in patients with breast...
Preoperative chemotherapy for locally advanced breast carcinoma at Charity Hospital, New Orleans, Louisiana
; ...subset of patients with breast carcinoma who do not...chemotherapy to these patients. The purpose...locally advanced breast carcinoma. Thirty-three...at 3 years. Patients who had a...locally advanced breast carcinoma, to preoperative...
Inflammatory Breast Carcinoma: Comparison of Survival of Those Diagnosed Clinically, Pathologically, or with Both Features
; ...a survival difference in patients with inflammatory breast carcinoma (IBC) with regard to whether...chart review of all the patients diagnosed with IBC who were...both features. INFLAMMATORY BREAST CARCINOMA (IBC), although uncommon...that 46 to 100 per cent of patients ...
Full-Thickness Chest Wall Resection for Recurrent Breast Carcinoma: An Institutional Review and Meta-analysis
; ...prognosis in patients with a disease-fr...resection for patients with isolated...cure in some patients. LOCOREGIONAL RECURRENCE of breast carcinoma can occur in...per cent of patients with breast...the number of patients with local recurrence...management of ...
Level III lymph node involvement in breast carcinoma
; ...histopathologically proven breast carcinoma patients underwent modified...selected group of patients. [Turk J Cancer...109-113] KEY WORDS: Breast carcinoma, level III lymph...histopathologically proven breast carcinoma patients who underwent...
Induction of prostate-specific antigen expression by synthetic progestins in patients with prostate and breast cancer / In reply
; ...Progestins in Patients With Prostate...observed in these patients, however. Recently...culture system and breast carcinoma cell lines, we...PSA levels in patients with breast cancer...about 50% of patients with breast cancer. Our study with breast ...